However, it is important to take into consideration the pleiotropic roles of the mitochondrial shaping proteins especially the fusion proteins, Mfn2 and OPA1, when targeting the mitochondrial shaping proteins as a treatment for cardiac disease. The gene discussed is PROS1; the disease is heart disorder.